OpiAID to develop an advanced wearable device to aid in treatment for opioid abuse by detecting biological indicators of overdose.
OpiAID has raised $2.8M in total funding. The most recent round was Grant. The last funding was announced in May 2023.
OpiAID's investors include One North Carolina Small Business Program, National Institute on Drug Abuse (NIDA).
OpiAID is headquartered in Wilmington, United States.
OpiAID to develop an advanced wearable device to aid in treatment for opioid abuse by detecting biological indicators of overdose.
OpiAID is at the Grant stage.
Free to use in articles, research, and reference works. Stable URL — will not change. Data on this page last updated .
"OpiAID — Funding & Investors." VCBacked, May 2, 2023, https://www.vcbacked.co/company/opiaid. Accessed November 14, 2026.
VCBacked. (2023). OpiAID — Funding & Investors. Retrieved November 14, 2026, from https://www.vcbacked.co/company/opiaid
{{cite web |title=OpiAID — Funding & Investors |url=https://www.vcbacked.co/company/opiaid |website=VCBacked |access-date=November 14, 2026}}Profile data sourced and verified per the VCbacked methodology · Last funding round dated
Work at OpiAID? Request a listing update